Vertex Pharmaceuticals: director Bruce I. Sachs received 92.694 shares

What happened Bruce I. Sachs, director, received 92.694 deferred stock units (derivative award) at $512.44 per unit on Oct 15, 2026, for a total reported value of $47,500. The filing lists the transaction as a grant, award or other acquisition (code A).

Key details

• Transaction date and price: Oct 15, 2026 — 92.694 deferred stock units at $512.44 per unit; total $47,500.
• Shares owned after the transaction: not reported in this filing.
• Footnote F1: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.
• Filing date and report period: filed Oct 19, 2026; period of report Oct 15, 2026.

Why it may matter This was an award of deferred stock units (a derivative grant), not an option exercise or a market sale; the units convert to common stock only under the conditions described in footnote F1. A filing does not show why the insider traded or why the company acted.